CLINICAL TRIAL DESIGN: THE REVOLUTION OF NEW STATISTICAL PRINCIPLES

2022-08-04T14:05:47+00:00July 6th, 2022|Categories: Meditrial|Tags: , , , , |

Edited by Dr. Monica Tocchi, Meditrial medical director. The organization called ICH (International council for harmonization of technical requirements for pharmaceuticals for human use) is a global organization that unites regulatory authorities and the pharmaceutical industry in the common [...]

CLINICAL EVIDENCE FOR IVDs: THE NEW GOOD CLINICAL PRACTICES

2022-08-04T14:21:10+00:00June 28th, 2022|Categories: Meditrial|Tags: , , , , , , , |

Atty. Alessia Nuciari, director of compliance Meditrial. The in vitro diagnostics industry has undergone a substantial transformation. IVDR Regulation 746/2017, published in May 2017 and applied from May 26, 2022, introduced major changes in the industry. The main [...]

OBSERVATIONAL STUDIES AND REGISTRIES: REAL WORLD EVIDENCE

2022-07-05T13:38:23+00:00June 15th, 2022|Categories: Meditrial|Tags: , , , , |

Dr. Paola Antonini, Meditrial scientific director. If well designed, observational studies and registries produce treatment effect data comparable in importance to those in randomized controlled trials,[1] generating information missing in traditional interventional studies and real-world data to support marketing [...]

THE NEW ROLE OF THE PATIENT AS AN ACTIVE PLAYER IN CLINICAL TRIALS

2022-07-06T15:23:20+00:00June 8th, 2022|Categories: Meditrial|Tags: , , , , , |

Research and innovation are based on rigorous clinical trials involving patients firsthand. The main actor in clinical trials is the patient affected by the disease under examination. Including the patient’s perspective allows us to reduce barriers that otherwise limit your [...]

NEW OPPORTUNITIES FOR SUCCESSFUL CLINICAL TRIALS.

2022-07-05T08:45:12+00:00May 25th, 2022|Categories: Meditrial|Tags: , , , |

The challenge of recruiting suitable patients into clinical trials has always been a significant obstacle to drug and medical device development programs. The difficulty of generating evidence delays the introduction of new medical interventions and results in high costs. [...]

DIETARY SUPPLEMENTS, THE CLINICAL TRIALS ROADMAP.

2022-07-05T13:37:51+00:00May 11th, 2022|Categories: Meditrial|Tags: , , , , , , , |

Paola Antonini, Meditrial Scientific Director. Due to the pandemic and the information shared on social media, the increased attention of individuals to their own health and well-being has led to a considerable increase in the consumption of food supplements [...]

CLINICAL DEVELOPMENT OF DRUGS AND MEDICAL DEVICES: AN OVERVIEW OF THE MOST INNOVATIVE AND INTERESTING ASPECTS.

2022-07-05T08:52:21+00:00May 4th, 2022|Categories: Meditrial|Tags: , , , , |

Clinical development is a term traditionally used to define the entire process of bringing a new drug or medical device to market. It includes a pre-clinical phase to support human use and a clinical trial phase on patients, in compliance [...]

Meditrial MDR DIVERSITY Germany Clinical Trials

2023-03-31T09:04:26+00:00May 6th, 2021|Categories: Europe, MDR, Regulatory|Tags: , , , , |

The medical device regulation EU 2017/745 allows Member States some adjustments for local implementation. If you sponsor a trial in Germany, you must learn what are the new ordinances and guidelines for the implementation of the MDR. [...]

Austria: medical device and IVD clinical trials submission process changes during transition to MDR

2023-03-31T09:12:27+00:00April 22nd, 2021|Categories: Clinical Trial, Europe, MDR|Tags: , , , , |

The Austrian Federal Office for Safety in Health Care (BASG) gave information on a new validation process during the transition to the MDR which will come into force in May 2021.Meditrial manages several studies in Austria and has direct connections [...]

Go to Top